NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -92.0% | 19,622 | -67.0% | 0.00% | – |
| Q3 2017 | $25,000 | -84.0% | 59,417 | -80.5% | 0.00% | – |
| Q2 2017 | $156,000 | -47.1% | 305,271 | -40.3% | 0.00% | -100.0% |
| Q1 2017 | $295,000 | -44.2% | 511,074 | -39.3% | 0.00% | 0.0% |
| Q4 2016 | $529,000 | -41.7% | 841,885 | -15.2% | 0.00% | -50.0% |
| Q3 2016 | $908,000 | +25.6% | 992,267 | -27.2% | 0.00% | 0.0% |
| Q2 2016 | $723,000 | +582.1% | 1,362,499 | +1616.9% | 0.00% | – |
| Q4 2015 | $106,000 | +107.8% | 79,356 | +191.8% | 0.00% | – |
| Q4 2014 | $51,000 | +2.0% | 27,192 | -20.3% | 0.00% | – |
| Q2 2014 | $50,000 | -30.6% | 34,100 | +25.2% | 0.00% | – |
| Q3 2013 | $72,000 | +38.5% | 27,227 | +41.1% | 0.00% | – |
| Q2 2013 | $52,000 | – | 19,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |